Literature DB >> 11320786

[Consumption of psychopharmaceuticals in residential facilities for the elderly. Evaluation of the extent, indications and effects].

L Nilsson1, C Petersson.   

Abstract

Previous studies have shown a high level of consumption of psychopharmacological drugs in nursing homes. A questionnaire study in Kronoberg County in the autumn of 1998 investigated treatment with psychopharmacological drugs at ten nursing homes with a total of 405 care recipients. The questionnaire included questions about the extent of treatment, indications, duration of treatment and evaluation routines. Some 59% of the recipients, with a variation of 48-73% in different homes, were in continuous treatment with psychopharmacological drugs. Disturbances of sleep, depression and anxiety accounted for 79% of all indications. For 84%, treatment duration was not time-limited ("until further notice"). Assessments by the care staff were the most common evaluation procedure. In only 43% of cases were patients' self-evaluations heeded. Neuroleptics were probably overused, often with indications other than psychotic symptoms. Repeated treatment evaluations involving different categories of staff are important if excessive medication is to be avoided.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320786

Source DB:  PubMed          Journal:  Lakartidningen        ISSN: 0023-7205


  3 in total

1.  Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland.

Authors:  Helka Hosia-Randell; Kaisu Pitkälä
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.

Authors:  Jonny Olsson; Asa Bergman; Anders Carlsten; Thimothy Oké; Cecilia Bernsten; Ingrid K Schmidt; Johan Fastbom
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study.

Authors:  E Clapham; R Bodén; J Reutfors; T Svensson; D Ramcharran; H Qiu; H Kieler; S Bahmanyar
Journal:  Acta Psychiatr Scand       Date:  2019-10-11       Impact factor: 6.392

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.